Now I have a thorough understanding of the paper and can cross-verify each claim. Let me produce the final consolidated review.

## Summary

This paper presents Marlene, a deep neural network for inferring time-varying gene regulatory networks (GRNs) from single-cell RNA-seq time series. The architecture combines (1) a set-based gene featurization step via Pooling by Multihead Attention (PMA), (2) a self-attention mechanism whose key/query projection weights are evolved by GRUs to produce time-specific adjacency matrices, and (3) model-agnostic meta-learning (MAML) to handle rare cell types by treating each cell type as a separate task. The model optimizes for cell-type classification as a proxy objective rather than direct expression reconstruction. Marlene is evaluated on three scRNA-seq datasets (SARS-CoV-2 vaccination, human lung aging, mouse lung fibrosis) with validation against two curated TF-gene interaction databases (TRRUST, RegNetwork), consistently outperforming static baselines and showing biologically plausible temporal dynamics.

## Strengths

1. **Novel architectural integration for the dynamic GRN problem.** The paper adapts EvolveGCN's GRU-based weight evolution to the key/query projections of a self-attention module (Section "Architecture of Marlene"), enabling time-varying, directed graphs from a "graphs of features" setup that standard temporal graph methods do not address. This is a principled and non-trivial adaptation.

2. **Consistent and statistically significant overlap with known regulatory databases.** Across three datasets, Marlene achieves strong overlap with TRRUST and RegNetwork, often with very high significance (e.g., B cells in the SARS-CoV-2 dataset: FDR ≤ 1e-67; classical monocytes in HLCA: FDR = 1e-76). It outperforms all static baselines (PIDC, GENIE3, GRNBoost2, SCODE, DeepSEM) in the majority of cell types. These results are quantified via Fisher's exact test with Benjamini-Hochberg correction.

3. **Plausible temporal dynamics that baselines fail to capture.** Marlene's IoU between consecutive graphs is lowest during the early immune response (days 0→2 after vaccination), progressively stabilizing — matching biological expectations. In contrast, TVGL gives near-constant IoU (overly smooth), Graphs4mer shows decreasing IoU (counterintuitive), and static methods show near-zero IoU across transitions (Section "Marlene recovers realistic dynamic transitions").

4. **Cross-species and cross-dataset generalization.** Marlene is successfully applied to human PBMCs, human lung cells, and a mouse lung fibrosis model, using species-specific TF databases (Section "Case study 3"). This demonstrates the method is not tied to a specific organism or tissue.

5. **Biologically meaningful enrichment of dynamic edges.** Genes added by Marlene at day 2 in the vaccination dataset enrich for SARS-CoV-2 related pathways (Interferon Gamma Response, TNF-alpha Signaling via NF-kB); in the aging dataset, dynamic edges enrich for age-related diseases (arthritis, lung disease). These enrichments go beyond static database overlap and demonstrate that the model identifies functionally relevant transitions.

6. **Computational efficiency.** Training on datasets with tens of thousands of cells and thousands of genes takes minutes on a single NVIDIA RTX 3060, making the method practical for large-scale studies.

## Weaknesses

### Fatal
None.

### Major

1. **Cell-type classification as proxy objective is not validated with control experiments.** The paper's central design choice — optimizing for cell-type classification rather than expression reconstruction — is motivated as a hypothesis (lines 54–55) but never tested. There is no ablation showing that the learned graph structure is actually *required* for the classification. A control with a fixed (e.g., identity or random) adjacency matrix, or a model that predicts cell type from TF expression alone without graph reconstruction, would directly test whether the proxy objective forces the self-attention to encode regulatory information. The database validation partially addresses this concern, but the paper would be substantially stronger if it demonstrated that the learned graph causally contributes to classification performance.

2. **MAML contribution is not validated by ablation.** The paper claims that meta-learning "enables the reconstruction of dynamic graphs even for rare cell types" (Abstract, Section "Meta learning for rare cell types") and presents this as a core contribution. However, no ablation compares Marlene with vs. without MAML (e.g., joint training across all cell types or per-cell-type training). The non-classical monocyte results (138 cells, >800 known links, FDR ≤ 1e-27) are impressive, but it is unclear whether a non-meta version would have failed. Without this comparison, the contribution of meta-learning remains a plausible but untested design choice.

3. **TVGL and Graphs4mer are used in comparisons but never introduced or cited.** The IoU analysis (Section "Marlene recovers realistic dynamic transitions") and the fibrosis case study compare against TVGL and Graphs4mer, yet neither method is described, cited, or introduced anywhere in the paper (no citation markers appear in the text for either). A reader cannot assess whether the implementations are appropriate, whether hyperparameters were tuned, or even what these methods are. Given that these methods are implicitly treated as dynamic baselines, omitting their introduction is a serious presentation gap.

4. **The TopK operation is underspecified to the point of irreproducibility.** In the core architecture description (line 82), `TopK(𝐆ₜ)` is applied to matrix 𝐆ₜ ∈ ℝ^{𝑔×𝑘}. It is never specified whether TopK is applied row-wise, column-wise, to the flattened vector, or what value of K is used. This operation provides the input to the GRUs that evolve the self-attention weights, making it a critical component that cannot be re-implemented from the paper.

### Minor

1. **MAML support/query split construction is not specified.** The paper states that support and query sets are used (lines 96–98), and that 5 inner steps are used (line 130), but it does not specify how support/query splits are constructed from each cell type — e.g., what fraction is support vs. query, how many cells per task, whether time points are split across cells or repeated. This is needed for reproducibility.

2. **Sparsification to top 2% of edges is not motivated.** The evaluation sparsifies all predicted networks to the top 2% of edges "to match the number of links in these databases" (line 126). While equal treatment across methods is fair, the paper does not report sensitivity to this threshold or discuss whether results are robust to other sparsity levels. This would be straightforward to address.

3. **GSEA interpretation of dynamic edges has a partial circularity concern.** The model is trained to predict cell type, so edges added at day 2 are likely to involve genes that are cell-type markers, which would naturally enrich for relevant pathways. This does not invalidate the enrichment results, but a stronger test would compare whether Marlene's dynamic edges are *more* enriched for known response processes than statically inferred edges from the same time points. The paper touches on this (Figure 2b) but does not make this comparative claim explicit.

4. **The loss computation over the temporal sequence could be clearer.** The forward pass description (lines 89–92 and Equation 2) describes reconstruction followed by pooling and linear layers, but the exact mechanism by which predictions from multiple time steps are aggregated into a single logit vector is somewhat vague. A pseudocode or algorithmic description of the full forward pass would help.

### Trivial
None.

## Nice-to-Haves

- **Ablation of the PMA step:** Replacing PMA with simpler pooling (e.g., mean pooling) would show whether the attention-based gene featurization is beneficial.
- **Sensitivity analysis for key hyperparameters:** Batch size, number of PMA seeds (currently 16), and the TopK threshold would be useful to report.
- **Include TVGL in the primary overlap (Fisher's test) evaluation** if feasible, or explicitly explain why it is excluded — this would preempt concerns about selective reporting.

## Removed Points

The following points from the reviews are removed as unreasonable, factually incorrect, or procedural violations:

1. **"The references are stripped, but no in-text citation or description appears"** — The reference to "stripped" references conflates a parser artifact with a content issue. However, the fact that TVGL and Graphs4mer lack any citation markers in the text is a real issue, which is retained in Major Weakness #3. The *reference section stripping* comment itself is removed per the instruction that parser artifacts should not be treated as author errors.

2. **Criticism that the paper should also cover "full-genome gene sets" and strategies for scaling** — The paper explicitly discusses this limitation (Section "Limitations," lines 208–209) and mentions FlashAttention as a possible solution. The criticism is already addressed by the paper.

3. **Criticism that TVGL and Graphs4mer should be in the primary overlap evaluation** — These are dynamic methods that produce qualitatively different outputs from the per-time-point static methods. Whether they can be evaluated in the same Fisher's exact test framework depends on their output format. The reviewer's framing that their absence makes the comparison "incomplete" is an opinion about experimental design, not a demonstrated flaw. The IoU and enrichment analyses provide a separate and appropriate evaluation for these methods.

4. **"The PMA gene featurization uses k=16 seed vectors, which seems very small" without evidence** — This is a generic concern about hyperparameter choice, not a demonstrated weakness. No evidence is given that 16 seeds are insufficient. Moved here as a Nice-to-Have.

## Novel Insights

None beyond the paper's own contributions.

## Suggestions

1. **Add a fixed-adjacency control:** Train Marlene with an identity or random adjacency matrix (frozen) and compare cell-type classification accuracy and database overlap against the learned-graph version. This directly tests whether the proxy objective forces the graph to encode regulatory information.

2. **Add a MAML ablation:** Train a version of Marlene without the meta-learning loop (standard joint training across cell types) and compare performance on rare cell types (e.g., non-classical monocytes with 138 cells). If MAML is crucial, the difference should be clear; if not, soften the claim.

3. **Define TopK precisely:** Specify whether it operates row-wise, column-wise, or on the flattened matrix, and report the K value used. Add pseudocode or an algorithm box for the full forward pass.

4. **Introduce and cite TVGL and Graphs4mer:** Add brief descriptions of these methods, including how they were configured and applied, and cite their original papers.

5. **Report sensitivity to the 2% sparsity threshold:** Show how overlap results change at 1%, 5%, etc., to confirm robustness.

## Score and Decision

This paper presents a genuinely novel architectural integration for an important problem (dynamic GRN inference from scRNA-seq), and the empirical results are compelling — showing strong, statistically significant overlap with known regulatory databases across multiple species and datasets, with biologically plausible temporal dynamics that competing methods fail to capture. The weaknesses, while real, do not invalidate the core contribution. The cell-type classification proxy and MAML contributions are plausible but untested design choices; the TopK underspecification and missing TVGL/Graphs4mer descriptions are presentation issues that can be corrected. The paper would be strengthened by targeted ablations and clarifications, but the main empirical findings are meaningful and well-supported.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Accept</orange>